APXT SPAC Offers Strong Long-Term Growth Potential

APXT stock has fallen by 33 percent from its highs. What’s the forecast for the APXT SPAC before it merges with AvePoint and when it the merger close date?

Ambrish Shah - Author

Mar. 11 2021, Updated 9:00 a.m. ET

Man holding a tablet and sitting next to a computer
Source: istock

Apex Technology Acquisition Corp. (APXT), a SPAC, saw its stock rise 0.3 percent on March 10. However, the stock is down 33 percent from its 52-week high. What’s the forecast for APXT stock before the SPAC merges with AvePoint? Will APXT rise or continue to fall?

Article continues below advertisement
Article continues below advertisement

The APXT SPAC is scheduled to take AvePoint public. AvePoint is the largest data management solutions provider for Microsoft cloud. The blank-check company is led by co-CEOs Jeff Epstein and Brad Koenig. The APXT and AvePoint merger is expected in the first quarter of 2021.

apxt stock outlook
Source: Unsplash
Article continues below advertisement

Why APXT SPAC stock is falling

APXT stock has risen by 20 percent since its IPO. Currently, it's down 33 percent from its all-time high, which it hit on December 28, 2020. The stock has been trending downwards since there has been a massive sell-off in SPACs. The sell-off might have been caused by the fall in the SPACs headed by billionaire Chamath Palihapitiya and Churchill Capital IV (CCIV). Also, the stock prices are under pressure as bond yields rise.

Details about the APXT and AvePoint merger date are developing.

The APXT and AvePoint merger is expected to close in the first quarter of 2021. The transaction, subject to approval by APXT shareholders and other customary closing conditions, is set to have a pro forma enterprise value of $1.7 billion. The combined entity will be listed on the Nasdaq Exchange under the ticker symbol “AVPT.”

Article continues below advertisement
Article continues below advertisement

The transaction will be funded by a combination of $352 million in cash held by APXT in trust and an additional $140 million in PIPE (private investment in public equity) from institutional investors. AvePoint is expected to have around $252 million in cash on its balance sheet when the deal closes. Existing AvePoint shareholders are set to own about 72 percent of the combined company when the deal closes.

AvePoint versus its peers

AvePoint competes with many players in the tech space including Alteryx (AYX) and Dynatrace (DT). AvePoint expects to generate sales of $148 million in 2020 and forecasts its sales to grow by 30 percent in 2021 and 33 percent in 2022. AvePoint's 2020 adjusted EBIT margin of around 14 percent also looks good.

Article continues below advertisement

Alteryx generated sales of $495.3 million in 2020. Meanwhile, Wall Street analysts expect the company’s sales to grow by 13.1 percent in 2021 and 20.8 percent in 2022. Dynatrace is expected to grow its sales by 28 percent in 2021 and 24.1 percent in 2022.

Article continues below advertisement

APXT’s valuation

APXT valued AvePoint at a pro forma implied equity value of $2.0 billion. Meanwhile, at APXT’s current stock price, AvePoint is valued at around $2.41 billion. In comparison, Alteryx and Dynatrace have market capitalizations of $5.72 billion and $14.44 billion, respectively.

Article continues below advertisement

In its presentation announcing the merger, AvePoint provided a valuation comparison. Its 2021 EV-to-sales multiple is 9.0x. In comparison, Alteryx’s and Dynatrace’s multiples are 14.3x and 11.3x, respectively.

apxt spac stock forecast
Source: Koyfin

APXT Stock Price

APXT SPAC stock is a buy before the merger

APXT SPAC stock could be a good buying opportunity based on its strong long-term growth potential and valuations. The market correction has brought the valuations of top SPACs more in line with their future growth outlook. AvePoint thinks that it has a total addressable market opportunity of $33 billion by 2022. The company is expected to increase its user base as more people worked from home amid the coronavirus pandemic. However, APXT SPAC stock is a speculative play until its merger with AvePoint closes.


Latest IPOs News and Updates

    Opt-out of personalized ads

    © Copyright 2024 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.